Global Corruption Report 2006

6,63
MB

378
stron

6278
ID Transparency International

2005
rok

Contents

Acknowledgements x

Preface xii

David Nussbaum

Foreword xiv

Mary Robinson

Executive summary xvi

Transparency International

Part one: Corruption and health

1 The causes of corruption in the health sector: a focus on health care systems 3

Why are health systems prone to corruption? 4

William D. Savedoff and Karen Hussmann

A tale of two health systems 14

William D. Savedoff

Corruption in health care systems: the US experience 16

Malcolm K. Sparrow

Corruption in Cambodia’s health sector 22

Lisa Prevenslik-Takeda

2 The scale of the problem 25

Case study: Grand corruption in Costa Rica 26

Emilia González

Measuring corruption in the health sector: what we can learn from public expenditure tracking and

service delivery surveys in developing countries 29

Magnus Lindelow, Inna Kushnarova and Kai Kaiser

Local-level corruption hits health service delivery in the Philippines 37

Omar Azfar and Tugrul Gurgur

Corruption is bad for your health: findings from Central and Eastern Europe 39

Richard Rose

‘Citizens’ audit’ in Mexico reveals paper trail of corruption 43

Helena Hofbauer

Fighting fraud and corruption in Britain’s National Health Service 46

Jim Gee

3 Corruption in hospitals 48

Corruption in hospital administration 49

Taryn Vian

Cash registers inject transparency – and revenue – into Kenya’s Coast Provincial General Hospital

53

Taryn Vian

Hospital waiting lists open for scrutiny in Croatia 55

Ana First

No bribes for healthy business: India’s Transasia Biomedicals 58

Michael Smith

4 Informal payments for health care 62

Paying for ‘free’ health care: the conundrum of informal payments in post-communist Europe 63

Sara Allin, Konstantina Davaki and Elias Mossialos

Gift, fee or bribe? Informal payments in Hungary 71

Péter Gaál

Informal payments take a toll on Moroccan patients 74

Azeddine Akesbi, Siham Benchekroun and Kamal El Mesbahi

5 Corruption in the pharmaceutical sector 76

Pharmaceuticals and corruption: a risk assessment 77

Jillian Clare Cohen

US pharmaceutical company fined for payments to charity headed by Polish health official 78

Transparency International

The corrupting influence of money in medicine 85

Jerome P. Kassirer

Promoting trust and transparency in pharmaceutical companies: an industry perspective 91

Harvey Bale

Fighting corruption: the role of the medical profession 94

John R. Williams

The fight against counterfeit drugs in Nigeria 96

Dora Akunyili

GC2006 00 pre 6 8/11/05 17:53:06

Global Corruption Report 2006 vii

Corruption in the Ministry of Public Health, Thailand 100

Stuart Cameron

Malpractice in the Office of the Drug Controller in Karnataka, India 101

Stuart Cameron

6 Corruption and HIV/AIDS 103

The link between corruption and HIV/AIDS 104

Liz Tayler and Clare Dickinson

Accountability in a time of crisis: corruption and the Global Fund 108

Toby Kasper

Corruption in Kenya’s National AIDS Control Council 112

Kipkoech Tanui and Nixon Ng’ang’a

Part two: Country reports

7 Lessons learned from anti-corruption campaigns around the world 119

Cobus de Swardt

8 Country reports

Algeria Djilali Hadjadj 123

Bangladesh Iftekhar Zaman, Sydur Rahman and Abdul Alim 126

Bolivia Guillermo Pou Munt Serrano 130

Brazil Ana Luiza Fleck Saibro 133

Burkina Faso Luc Damiba 136

Cameroon Jean-Bosco Talla and Maurice Nguéfack 139

China Guo Yong and Liao Ran 142

Costa Rica Roxana Salazar 146

Croatia Ana First 149

Ecuador Andrés Tobar 152

Finland Santeri Eriksson 154

France Antoine Genevois 157

Georgia Daria Vaisman 160

Greece Markella Samara 164

Guatemala Alejandro Urizar 168

Ireland Elaine Byrne 172

Israel Doron Navot 176

Japan Transparency International Japan 181

Kazakhstan Sergey Zlotnikov 184

Kenya Wachira Maina and Noelina Nabwire 188

Kuwait Kuwait Economic Society 191

Kyrgyzstan Aigul Akmatjanova 195

Malaysia Mehrun Siraj and Sunita Chima 199

Morocco Azeddine Akesbi, Siham Benchekroun, Kamal El Mesbahi, Rachid Filali Meknassi and

Michèle Zirari 203

Nepal Rama Krishna Regmee 206

New Zealand Shane Cave 210

Nicaragua Roberto Courtney 213

Panama Angélica Maytín Justiniani 216

Papua New Guinea Transparency International Papua New Guinea 220

Peru Samuel Rotta Castilla and

Leonardo Narvarte Olivares 223

Poland Julia Pitera 227

Romania Adrian Savin 230

Serbia Nemanja Nenadic 235

Slovakia Emilia Sicáková-Beblavá 239

South Africa Ayesha Kajee 242

South Korea Geo-Sung Kim 246

Spain Manuel Villoria 250

Sri Lanka Anushika Amarasinghe 253

Switzerland Jeffrey Nilsen, Anne Schwöbel and Stefanie Teickner 257

Uganda Charles Mubbale and Paul Onapa 261

Ukraine Transparency International 265

United Kingdom Transparency International (UK) 267

United States of America Nancy Izzo Jackson with Michael Johnston, Mark Glaze, Holly Gregory

and Chris Yukins 272

Vanuatu Anita Jowitt 277

Venezuela Transparencia Venezuela 280

Part three: Research on corruption

9. Introduction 287

Robin Hodess

10. Ten years of the CPI: determining trends 292

Johann Graf Lambsdorff

11. Corruption Perceptions Index 2005 298

Johann Graf Lambsdorff

12. Governance matters IV: new data, new challenges 304

Daniel Kaufmann, Aart Kraay and Massimo Mastruzzi

13. Corruption in the United States of America 308

Edward Glaeser and Raven Saks

14. Transparency and its impact on financial fragility 312

Saadia Zahidi

15. Budget transparency survey 315

Pamela Gomez

16. Beyond the rhetoric: measuring revenue transparency in the oil and gas industry 319

Elizabeth Lort-Phillips and Vanessa Herringshaw

17. Benchmarking corporate reputation: an incentive for good anti-corruption practice 323

Transparencia Mexicana